Skip to main content
. 2023 Jul 11;28(12):5380–5389. doi: 10.1038/s41380-023-02166-0

Fig. 5. TLR9-signaling induced cytokines reduce IL-1β and TNFα release from human iPSC-derived microglia.

Fig. 5

Conditioned media were collected from PBMCs after treatment with 1 μM TLR9 agonist ODN2216 (Donor#_TLR9; containing mixture of TLR9-signaling induced cytokines) or vehicle (Donor#_CT) and were diluted 10-fold to pre-treat human iPSC-derived microglial cultures for ~14 h. After the pre-treatment, microglial cultures were subjected to LPS priming for 4 h and nigericin stimulation (inflammasome activation) for 2 h. The supernatants from microglial cultures were collected for cytokine measurement by MSD multiplex assay. The concentrations of measured cytokines are plotted in chart (A) IL-1β, (B) TNFα, (C) IL-10, and the CellTiter measurements are plotted in chart (D). PBMCs were prepared from four healthy donors (Donor 1-Donor 4). Biological replicates from n = 3 independent experiments (each experiment with 3 biological replicates) are plotted in small-sized orange squares, mean values of biological replicates per experiment are plotted in black dots. Mean ± SD, One-way ANOVA with Fisher’s LDS pairwise comparisons of mean values from independent experiments. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ns (not significant).